The iShares MSCI Israel ETF (EIS) is trading near its 52-week high following a substantial rally, fueled by robust domestic equity performance, significant investor inflows, and major technology sector transactions over the past year. The fund’s trajectory raises questions about the sustainability of its current momentum.
Performance and Key Metrics
Recent performance figures underscore the fund’s strength. Over a one-year period, it has delivered gains estimated between 48% and 55%, with a year-to-date increase of 5.7%. As of the latest data, the fund manages approximately $717.6 million in assets and carries an expense ratio of 0.59%.
Liquidity remains consistent, with a 30-day average volume near 93,800 shares and a recent daily volume around 100,200 shares. The fund has also seen substantial net inflows, attracting roughly $308 million over the last twelve months. Its market price has traded at a narrow premium to its net asset value, typically between +0.3% and +0.45%, indicating efficient market pricing.
Portfolio Composition and Sector Exposure
This ETF offers physical exposure to the MSCI Israel Capped Investable Market Index, holding between 110 and 120 individual securities. A notable feature is its high concentration: the top ten holdings account for about 52% of the total portfolio. Major positions include Teva Pharmaceutical, Bank Leumi, Bank Hapoalim, CyberArk, and Elbit Systems. This concentration means the performance of a few key companies can significantly impact the overall fund.
Should investors sell immediately? Or is it worth buying iShares MSCI Israel ETF?
From a sector perspective, financials represent the largest allocation at approximately 32%. Technology is the second-largest sector, comprising nearly 25% of the fund, followed by industrial, healthcare, and real estate companies. This provides a broader exposure to the Israeli economy compared to more narrowly focused technology competitors.
Drivers and Forward-Looking Considerations
Several structural factors could support continued interest. The Tel Aviv Stock Exchange’s shift to a Monday-Friday trading week is expected to improve market accessibility for international investors. Furthermore, significant deals and investments by global corporations into Israel’s cybersecurity and artificial intelligence firms highlight the enduring appeal of its tech sector. The Bank of Israel projects robust GDP growth of around 5.2% for 2026, which may bolster corporate earnings prospects.
However, the strong gains witnessed in 2025 have elevated valuations. The fund’s near-term path is likely tied to the performance of its dominant sectors. A sustained rally in the TA-125 index would likely benefit EIS, while pronounced weakness in technology or financial stocks could place the ETF under considerable pressure. Key indicators to monitor in the coming weeks include the trajectory of the TA-125, continued fund flow data, and fundamental news from the ETF’s largest holdings.
Ad
iShares MSCI Israel ETF Stock: Buy or Sell?! New iShares MSCI Israel ETF Analysis from January 17 delivers the answer:
The latest iShares MSCI Israel ETF figures speak for themselves: Urgent action needed for iShares MSCI Israel ETF investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from January 17.
iShares MSCI Israel ETF: Buy or sell? Read more here...








